1. Home
  2. MNMD vs MTLS Comparison

MNMD vs MTLS Comparison

Compare MNMD & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • MTLS
  • Stock Information
  • Founded
  • MNMD 2019
  • MTLS 1990
  • Country
  • MNMD United States
  • MTLS Belgium
  • Employees
  • MNMD N/A
  • MTLS 2437
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • MTLS Computer Software: Prepackaged Software
  • Sector
  • MNMD Health Care
  • MTLS Technology
  • Exchange
  • MNMD Nasdaq
  • MTLS Nasdaq
  • Market Cap
  • MNMD 485.5M
  • MTLS 467.2M
  • IPO Year
  • MNMD N/A
  • MTLS 2014
  • Fundamental
  • Price
  • MNMD $7.81
  • MTLS $8.03
  • Analyst Decision
  • MNMD Strong Buy
  • MTLS Buy
  • Analyst Count
  • MNMD 9
  • MTLS 1
  • Target Price
  • MNMD $28.75
  • MTLS $9.50
  • AVG Volume (30 Days)
  • MNMD 1.1M
  • MTLS 197.3K
  • Earning Date
  • MNMD 11-07-2024
  • MTLS 10-24-2024
  • Dividend Yield
  • MNMD N/A
  • MTLS N/A
  • EPS Growth
  • MNMD N/A
  • MTLS 323.01
  • EPS
  • MNMD N/A
  • MTLS 0.19
  • Revenue
  • MNMD N/A
  • MTLS $297,100,156.00
  • Revenue This Year
  • MNMD N/A
  • MTLS $8.48
  • Revenue Next Year
  • MNMD N/A
  • MTLS $9.65
  • P/E Ratio
  • MNMD N/A
  • MTLS $42.17
  • Revenue Growth
  • MNMD N/A
  • MTLS 5.07
  • 52 Week Low
  • MNMD $3.35
  • MTLS $4.70
  • 52 Week High
  • MNMD $12.22
  • MTLS $8.50
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 56.42
  • MTLS 60.40
  • Support Level
  • MNMD $6.89
  • MTLS $7.70
  • Resistance Level
  • MNMD $7.58
  • MTLS $8.49
  • Average True Range (ATR)
  • MNMD 0.46
  • MTLS 0.38
  • MACD
  • MNMD -0.03
  • MTLS -0.04
  • Stochastic Oscillator
  • MNMD 55.25
  • MTLS 60.83

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

About MTLS Materialise NV

Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.

Share on Social Networks: